Carlos A. Bonilla-Aya
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia.
Journal: Haematologica
Published: September 13, 2023
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.
Journal: Leukemia
Published: April 30, 2022
Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells.
Journal: British journal of cancer
Published: December 03, 2019
Melanoma circulating tumor cells: Benefits and challenges required for clinical application.
Journal: Cancer letters
Published: November 24, 2017
Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device.
Journal: Oncotarget
Published: March 10, 2017
In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
Journal: BMC genomics
Published: January 21, 2014
High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
Journal: Genes, chromosomes & cancer
Published: July 16, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026